Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients
- PMID: 27432511
- PMCID: PMC4962757
- DOI: 10.12659/msm.898866
Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients
Abstract
BACKGROUND Portal venous system thrombosis (PVST) is a life-threatening complication of liver cirrhosis. We conducted a retrospective study to comprehensively analyze the prevalence and risk factors of PVST in liver cirrhosis. MATERIAL AND METHODS All cirrhotic patients without malignancy admitted between June 2012 and December 2013 were eligible if they underwent contrast-enhanced CT or MRI scans. Independent predictors of PVST in liver cirrhosis were calculated in multivariate analyses. Subgroup analyses were performed according to the severity of PVST (any PVST, main portal vein [MPV] thrombosis >50%, and clinically significant PVST) and splenectomy. Odds ratios (ORs) and 95% confidence intervals (CIs) were reported. RESULTS Overall, 113 cirrhotic patients were enrolled. The prevalence of PVST was 16.8% (19/113). Splenectomy (any PVST: OR=11.494, 95%CI=2.152-61.395; MPV thrombosis >50%: OR=29.987, 95%CI=3.247-276.949; clinically significant PVST: OR=40.415, 95%CI=3.895-419.295) and higher hemoglobin (any PVST: OR=0.974, 95%CI=0.953-0.996; MPV thrombosis >50%: OR=0.936, 95%CI=0.895-0.980; clinically significant PVST: OR=0.935, 95%CI=0.891-0.982) were the independent predictors of PVST. The prevalence of PVST was 13.3% (14/105) after excluding splenectomy. Higher hemoglobin was the only independent predictor of MPV thrombosis >50% (OR=0.952, 95%CI=0.909-0.997). No independent predictors of any PVST or clinically significant PVST were identified in multivariate analyses. Additionally, PVST patients who underwent splenectomy had a significantly higher proportion of clinically significant PVST but lower MELD score than those who did not undergo splenectomy. In all analyses, the in-hospital mortality was not significantly different between cirrhotic patient with and without PVST. CONCLUSIONS Splenectomy may increase by at least 10-fold the risk of PVST in liver cirrhosis independent of severity of liver dysfunction.
Similar articles
-
A novel method detecting the key clinic factors of portal vein system thrombosis of splenectomy & cardia devascularization patients for cirrhosis & portal hypertension.BMC Bioinformatics. 2019 Dec 30;20(Suppl 22):720. doi: 10.1186/s12859-019-3233-3. BMC Bioinformatics. 2019. PMID: 31888439 Free PMC article.
-
Predictors of portal vein system thrombosis after laparoscopic splenectomy and azygoportal disconnection: A Retrospective Cohort Study of 75 Consecutive Patients with 3-months follow-up.Int J Surg. 2016 Jun;30:143-9. doi: 10.1016/j.ijsu.2016.04.047. Epub 2016 May 4. Int J Surg. 2016. PMID: 27154616
-
Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism.J Laparoendosc Adv Surg Tech A. 2016 Jun;26(6):419-23. doi: 10.1089/lap.2015.0481. Epub 2016 Mar 8. J Laparoendosc Adv Surg Tech A. 2016. PMID: 26953863
-
Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis.Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):125-131. doi: 10.1097/MEG.0000000000001774. Eur J Gastroenterol Hepatol. 2021. PMID: 32501878
-
Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis.PLoS One. 2023 Aug 15;18(8):e0290164. doi: 10.1371/journal.pone.0290164. eCollection 2023. PLoS One. 2023. PMID: 37582105 Free PMC article.
Cited by
-
Portal vein thrombosis risk factors in liver transplant candidates.Hepatol Forum. 2022 Sep 23;3(3):88-92. doi: 10.14744/hf.2022.2022.0005. eCollection 2022 Sep. Hepatol Forum. 2022. PMID: 36177096 Free PMC article.
-
No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010969. doi: 10.1177/10760296211010969. Clin Appl Thromb Hemost. 2021. PMID: 33882699 Free PMC article.
-
Measurement of Exhaled Nitric Oxide in Cirrhotic Patients with Esophageal and Gastric Varices.Biomed Res Int. 2019 Nov 3;2019:9673162. doi: 10.1155/2019/9673162. eCollection 2019. Biomed Res Int. 2019. PMID: 31781658 Free PMC article.
-
Research Progress in Chinese Medicine Preparations for Promoting Blood Circulation and Removing Blood Stasis for Cirrhotic Patients with Portal Vein Thrombosis Following Splenectomy.Chin J Integr Med. 2022 Sep;28(9):855-863. doi: 10.1007/s11655-020-3271-8. Epub 2020 Jul 20. Chin J Integr Med. 2022. PMID: 32691285 Review.
-
Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study.Abdom Radiol (NY). 2022 Oct;47(10):3615-3627. doi: 10.1007/s00261-022-03600-7. Epub 2022 Jul 12. Abdom Radiol (NY). 2022. PMID: 35821274
References
-
- De Stefano V, Martinelli I. Splanchnic vein thrombosis: Clinical presentation, risk factors and treatment. Intern Emerg Med. 2010;5:487–94. - PubMed
-
- Valla DC, Condat B. Portal vein thrombosis in adults: Pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–71. - PubMed
-
- Chen H, Turon F, Hernandez-Gea V, et al. Non-tumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl. 2016;22(3):352–65. - PubMed
-
- Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med. 2008;3:213–18. - PubMed
-
- Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol. 2014;11:435–46. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical